☆ 4.7 Meeting Abstract

Oral Semaglutide vs. Empagliflozin Added On to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2

DIABETES (2019)

Get Full Text
Add to Collection

Journal

DIABETES
Volume 68, Issue -, Pages -

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db19-54-OR

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Novo Nordisk A/S

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.